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cells in these encephalitides. Our results show that large 
numbers of inflammatory cytotoxic T cells are present in 
PML lesions. Whereas in HSVE and CMVE, single or 
multiple appositions of CD8+ or granzyme-B+ T cells to 
infected cells are found, in PML such appositions are sig-
nificantly less apparent. Analysis of apoptotic pathways by 
markers such as activated caspase-3, caspase-6, poly(ADP-
ribose) polymerase-1 (PARP-1) and apoptosis-inducing 
factor (AIF) showed upregulation of caspase-3 and loss of 
caspase-6 from mitochondria in CMVE and HSVE infected 
cells. Infected oligodendrocytes in PML did not upregu-
late activated caspase-3 but instead showed transloca-
tion of PARP-1 from nucleus to cytoplasm and AIF from 
mitochondria to nucleus. These findings suggest that in 
HSVE and CMVE, cells die by caspase-mediated apoptosis 
induced by cytotoxic T cells. In PML, on the other hand, 
infected cells are not eliminated by the immune system but 
seem to die by virus-induced PARP and AIF translocation 
in a type of cell death defined as parthanatos.
Keywords Virus encephalitis · Progressive multifocal 
leucoencephalopathy · Cytomegalovirus · Herpes 
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Introduction
Progressive multifocal leukoencephalopathy (PML) is a 
demyelinating and often fatal disease caused by infection 
of oligodendrocytes and astrocytes in human brain [50]. It 
is thought to be initiated by immunosuppression-associated 
reactivation of latent JC virus and was first seen in immu-
nosuppressed cancer patients and organ transplant recipi-
ents [2]. PML reached epidemic proportions as a major 
Abstract During the appearance of human immunode-
ficiency virus infection in the 1980 and the 1990s, pro-
gressive multifocal leukoencephalopathy (PML), a viral 
encephalitis induced by the JC virus, was the leading 
opportunistic brain infection. As a result of the use of mod-
ern immunomodulatory compounds such as Natalizumab 
and Rituximab, the number of patients with PML is once 
again increasing. Despite the presence of PML over dec-
ades, little is known regarding the mechanisms leading 
to death of infected cells and the role the immune system 
plays in this process. Here we compared the presence of 
inflammatory T cells and the targeting of infected cells by 
cytotoxic T cells in PML, herpes simplex virus encephali-
tis (HSVE) and cytomegalovirus encephalitis (CMVE). In 
addition, we analyzed cell death mechanisms in infected 
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complication in acquired immune deficiency syndrome 
(AIDS) patients [9, 37]. In recent years, PML has been 
observed in patients treated with immunomodulatory com-
pounds such as Natalizumab [26, 27, 29, 43] and Rituximab 
[17]. Generally, it is assumed that infected oligodendrocytes 
are eliminated by cytotoxic T lymphocytes. Indeed, JC-spe-
cific T cells can be detected in the blood of PML patients 
[31] and such cytotoxic CD8+ T cells have been found to 
enter the central nervous system (CNS) where they come 
into contact with JC-infected cells [48]. Nevertheless, at pre-
sent there is no clear in situ evidence that these cytotoxic T 
cells are actively engaged in the elimination of infected cells.
Surprisingly little is known about the cause of oligo-
dendrocyte cell death in PML. Some evidence of apoptosis 
of oligodendrocytes was shown in 2002 [41]. Others how-
ever demonstrated that infected oligodendrocytes start to 
express the anti-apoptotic factor surviving in order to delay 
apoptosis [40]. Since the first descriptions of programmed 
cell death mechanisms there has been a tendency to use 
only two categories; either cells die by apoptosis or by 
necrosis. At present it has become clear that there are many 
different pathways in which a large variety of molecules 
play a distinct role [24]. Besides the caspase-dependent 
apoptosis pathways, there is a caspase-independent path-
way which involves the DNA damage-responsive enzyme 
poly(ADP-ribose) polymerase-1 (PARP-1). At the molecu-
lar level, expression of PARP-1 leads to formation and 
release of poly(ADP-ribose) (PAR) from the nucleus. In 
mitochondria, PAR induces release of apoptosis-inducing 
factor (AIF). AIF redirects from the mitochondria towards 
the nucleus and mediates chromatinolysis, resulting in so-
called regulated necrosis [24]. This cell death pathway has 
been designated as parthanatos and has been suggested to 
play a role in a variety of pathophysiological conditions 
such as stroke and diabetes [18].
Here we analyzed cytotoxic T cell mechanisms and cell 
death pathways in (AIDS-associated) viral encephalitides 
PML and cytomegalovirus encephalitis (CMVE) as well 
as herpes simplex virus encephalitis (HSVE). Our findings 
suggest that in CMVE and HSVE, cells are eliminated by 
the immune system via a caspase-mediated pathway. In 
PML, infected oligodendrocytes, rather than being elimi-
nated by cytotoxic T lymphocytes, undergo parthanatos 




This study was performed on paraffin-embedded, formalin-
fixed archival material that was collected between 1982 and 
1998 in the Department of Neurology at the Hospital Lainz 
in Vienna, Austria. The samples consisted of eight cases 
of AIDS-associated PML, seven cases of AIDS-associated 
CMVE, five cases of HSVE and five control (no neuro-
logical disease) brains. The histopathological diagnosis of 
these cases was established by an experienced neuropathol-
ogist (KJ). Demographic data of the individual patients are 
presented in Table 1.
Histopathology and immunohistochemistry
4 μm sections of paraffin-embedded specimens were rou-
tinely stained with hematoxylin and eosin (H&E) and 
luxol fast blue/periodic acid-Schiff (LFB-PAS) for myelin. 
Immunohistochemical stainings were performed accord-
ing to previously published protocols [5, 11] using pri-
mary antibodies against inflammatory T cells [CD3, CD8, 
CD4 and Granzyme-B (GrB)] and other inflammatory 
cells such as CD20+ B cells and CD138+ plasma cells. For 
CD3, CD8, CD4 and GrB stainings, biotinylated tyramine 
enhancement was used as described previously [10]. For 
analysis of cell death pathways we used antibodies against 
activated caspase-3 (CM1), caspase-6, Poly(ADP-ribose) 
(PAR) and apoptosis-inducing factor (AIF). For detec-
tion of virus-infected cells we used monoclonal Pab2003 
[12] and monoclonal and polyclonal anti-SV40 [15], an 
antibody against CMV antigens and antibodies recogniz-
ing HSV-1. Light microscopical double-stainings for viral 
proteins and GrB or cell death markers (caspase-3) were 
done with an alkaline-phosphatase system (development 
with Fast Blue) and a peroxidase system (development with 
3,3′-Diaminobenzidine (DAB) or amino ethyl carbazole 
(AEC) as described in detail [7]. Details on the individ-
ual antibodies are listed in Supplementary Table 1 (online 
resource 1).
Confocal laser fluorescence microscopy
Fluorescence immunohistochemistry was performed on 
paraffin sections as previously described in detail [7]. For 
confocal fluorescent double-labeling or triple labeling with 
primary antibodies from different species, antibodies were 
applied simultaneously at 4 °C overnight. After washing 
with DAKO washing buffer (DakoCytomation, Glostrup, 
Denmark), secondary antibodies consisting of donkey-anti-
mouse Cy3 or donkey-anti-mouse Dylight 546 (Jackson 
ImmunoResearch, 1:200), biotinylated donkey-anti-rabbit 
(Amersham Pharmacia Biotech; 1:200) and (in case of triple 
labeling) Cy5-conjugated donkey-anti-goat, were applied 
simultaneously for 1 h at room temperature, followed by 
application of streptavidin-Cy2 (Jackson ImmunoResearch; 
1:75) for 1 h at room temperature. Fluorescent prepara-
tions were then stained with 4′,6′-diamidino-2-phenylindole 
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(DAPI, Sigma) or TO-PRO-3 (Thermo Scientific, Waltham, 
MA, USA) as nuclear counterstain, embedded and exam-
ined using a confocal laser scan microscope (Leica SP5, 
Leica Mannheim, Germany) equipped with lasers for 
504, 488, 543 and 633 nm excitation. Scanning for DAPI 
(504 nm), Cy2 (488 nm), Cy3 (543 nm), Cy5 (633 nm) or 
TO-PRO-3 (633 nm) was performed sequentially to rule out 
fluorescence bleed through.
Quantification of cells
Quantification of CD3+, CD8+, CD4+, GrB+, CD20+ B 
cells, CD138+ plasma cells and virus-infected SV40+, 
HSV+ or CMV+ cells was performed in 5.8 mm2 of tis-
sue regions exhibiting infected cells and inflammation. 
Typically, in PML, such areas were on the active border of 
large confluent chronic lesions or in small active lesions. 
In CMVE cases, infected cells were mostly found paraven-
tricular (four cases) in nuclei in medulla oblongata (three 
cases) or in the cerebellar molecular layer (one case). In 
order to quantitate appositions of CD8+ or GrB+ cells 
with virus-infected cells we used light microscopically 
double-labeled sections as described above. In each case 
we screened 500 infected cells for the presence of single 
(one CD8+ or GrB+ cell attached to a virus-infected cell) 
or multiple (two or more CD8+ or GrB+ cells in direct con-
tact with an infected cell) appositions. CD8+ cells were 
assessed at 200-fold magnification while GrB+ cells were 
assessed at a 400-fold magnification to be able to see the 
small granular signal.
Quantification of TPPP/p25+ oligodendrocytes in white 
matter of control brains, PML, HSVE and CMVE was per-
formed using an ocular morphometric grid covering an area 
of 0.25 mm2 at 200-fold magnification in 2 mm2 of tissue 
regions exhibiting infected cells and inflammation (lesions) 
and in 2 mm of the surrounding (normal appearing) white 
matter.
Quantification of the percentage of virus-infected cells 
with caspase-3 immunoreactivity or with nuclear AIF 
reactivity was performed on light microscopically double-
labeled sections. In each case we analyzed 500 infected 
cells at a 400-fold magnification.
Table 1  Demographic data of the patients
Sample number Disease Age Male/female Disease duration (week) Sample area Cause of death
12–93 PML (AIDS-assoc.) 45 Male 118 Lenticular nucleus Pulmonary edema
47–93 PML (AIDS-assoc.) 42 Male 20 Pons Pneumonia
97–93 PML (AIDS-assoc.) 50 Male 20 Parietal lobe right Pulmonary edema
103–93 PML (AIDS-assoc.) 39 Male 15 Parietal lobe left Acute respiratory 
insufficiency
278–93 PML (AIDS-assoc.) 29 Male 19 Parietal lobe left Cachexia
291–93 PML (AIDS-assoc.) 49 Female 5 Parietal lobe right Pneumonia
358–93 PML (AIDS-assoc.) 39 Male 27 Parietal lobe left Pneumonia
359–93 PML (AIDS-assoc.) 34 Male <18 Pons Pneumonia
330–82 HSV 9 Female 1.5 Hippocampus Acute respiratory 
insufficiency
67–83 HSV 40 Male 3.5 Hippocampus Necrotic hemorrhagic 
pneumonia
204–83 HSV 61 Female 1.5 Hippocampus Pneumonia
529–84 HSV 37 Male 2.3 Hippocampus Pneumonia
237–91 HSV 76 Male 3.15 Hippocampus Pneumonia
364–92 CMV (AIDS-assoc.) 40 Male unknown Parahippocampal region Acute cardiovascular 
failure
455–92 CMV (AIDS-assoc.) 48 Male <5 Parahippocampal region Pneumonia, sepsis
559–92 CMV (AIDS-assoc.) 33 Male 20 Cerebellum Pneumonia
234–93 CMV (AIDS-assoc.) 28 Male 11 Medulla oblongata Pneumonia, sepsis
430–93 CMV (AIDS-assoc.) 35 Male 15 Medulla oblongata Pneumonia
62–94 CMV (AIDS-assoc.) 32 Male >4 Medulla oblongata Pneumonia, sepsis
118–94 CMV (AIDS-assoc.) 55 Male 9 Hippocampus Pneumonia
Control brains – 50 (37–83) 3 Female
2 Male
– Cortex Non-neurological
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Statistics
Statistical analysis was performed with Graphpad Prism 
6.0. For metric data, a two-sided Mann–Whitney U test; 
and for categorical data, a two-sided chi square or Fisher 





16 sections from 8 cases of PML were stained with LFB-
PAS for detection of demyelinating lesions. Three cases 
contained one large lesion with a demyelinated core and 
with active demyelination on the border. Another two cases 
contained both large demyelinated lesions as well as mul-
tiple smaller demyelinating lesions. The remaining three 
cases had multiple smaller lesions (Fig. 1a). Quantification 
of oligodendrocytes in white matter showed a significant 
loss in and outside of PML lesions as compared to white 
matter of normal control brain (online resource 1, Suppl. 
Fig. 1). All cases were stained with Pab2003, an antibody 
recognizing early JCV T proteins [12]. Double-staining 
of Pab2003 with SV40 showed that most cells (64.5%) 
were double-labeled (Fig. 1b) while 6.5% were only posi-
tive for Pab2003 and 29% were only positive for SV40. 
Since the anti-SV40 antibody recognized more infected 
cells, we proceeded with this marker. In small demyeli-
nating lesions SV40+ oligodendrocytes were located on 
the border (Fig. 1c). Unlike the larger lesions which had 
many (bizarre) astrocytes in the core of the lesion (Fig. 1d, 
e), these small lesions did not contain bizarre astrocytes. 
SV40+ oligodendrocytes, double-labeled with carbonic 
anhydrase II (CAII), typically had a round swollen nucleus 
and enlarged cytoplasm (Fig. 1f). Basic inflammation was 
analyzed by H&E staining showing lymphocytes in the 
perivascular space of blood vessels as well as infiltration 
in the parenchyma of the CNS. Demyelinating lesions also 
contained macrophages (Fig. 1d) with LFB+ and/or PAS+ 
myelin degradation products.
HSV encephalitis
Five sections from five cases showed acute haemorrhagic 
and subacute necrotizing lesions in both white and gray 
matter areas (Fig. 1g). Lesional sites in HSVE contained 
large numbers of inflammatory infiltrates with T lympho-
cytes and macrophages in meninges, the perivascular space 
of blood vessels and the CNS parenchyma. Numerous 
infected cells could be recognized by the presence of 
nuclear inclusions. The full amount of infected cells how-
ever only became clear after staining for HSV1, which 
showed HSV antigens in the nuclei and cytoplasm (Fig. 1h) 
of large numbers of infected astrocytes (Figs. 1i, 5b), corti-
cal neurons (Fig. 1j) and oligodendrocytes (Fig. 1k). Like 
in PML, loss of oligodendrocytes in lesions was shown by 
quantification of stainings for TPPP/p25 (online resource 1, 
Suppl. Fig. 1).
CMV encephalitis
H&E sections showed the presence of large, often necrotic 
lesions with moderate infiltration of inflammatory lym-
phocytes (Fig. 1l). CMV-infected cells were recognized 
by their enlarged cytoplasm and characteristic “owl’s eye” 
morphology. Smaller infected cells in H&E sections were 
more difficult to detect but were easily found in sections 
stained with anti-CMV antibodies (Fig. 1m). Double-stain-
ing for CMV and GFAP showed that most of these cells 
were astrocytes (Fig. 1n) while oligodendrocytes were 
all negative for CMV (Fig. 1o). Nine sections from seven 
cases were studied for the presence of CMV positive cells. 
Almost all infected areas were found in gray matter. In four 
cases, groups of infected cells were found in a paraven-
tricular position near the hippocampus. In addition, in these 
cases we found incidental single cells in cortical regions. 
Often these cells were observed in the midst of a micro-
glial nodule. In one of these four cases a large haemor-
rhagic lesion was found in the hippocampus itself. In this 
patient we observed foci of CMV+ cells in cortical subpial 
positions. In one case, infected cells were present in small 
lesions of the molecular layer of the cerebellum (Fig. 1m) 
and in a large haemorrhagic lesion in the cerebellum. Such 
a large haemorrhagic lesion also was found in the medulla 
oblongata of a third patient. In one patient we only found 
single CMV+ cells dispersed over the medulla oblon-
gata. Again, such cells were often found to be surrounded 
by microglial cells as part of a microglial nodule. Like in 
PML and HSVE we also quantified oligodendrocytes in the 
white matter but did not find any loss (online resource 1, 
Suppl. Fig. 1).
T cell cytotoxicity in virus‑infected brains
To gain information on the role of inflammation in these 
encephalitides, we investigated these brains with vari-
ous markers for inflammatory cells. Stainings for CD57 
in PML, HSVE and CMVE demonstrated that NK cells 
were very rare and were mostly found in the perivascular 
space (online resource 1, Suppl. Fig. 2). CD20+ B cells and 
CD138+ plasma cells were more abundant than NK cells 
but less abundant than T cells (Fig. 3a). These B cells and 
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plasma cells were mostly present in the perivascular space 
(Suppl. Fig. 2f and 2g). Stainings for CD3 (Fig. 2a–c) 
showed that T cells were present in meninges, perivascular 
space and deeply infiltrated in the parenchyma. Double-
staining for CD8 and GrB showed that more than 95% of 
all GrB reactivity could be found in the CD8+ cells (online 
resource 1, Suppl. Fig. 2a). In all three forms of encephalitis 
we selected areas with prominent viral presence and quanti-
fied various T cell subsets in the parenchyma. Quantifica-
tion revealed that in CMVE less CD3+ T cells were present 
than in PML and HSVE (Fig. 3a). In addition, quantification 
of CD4+ T Helper cells showed that their numbers were 
lower in CMVE and PML than in HSVE (Fig. 3a and Supp. 
Fig. 2D and E). The latter probably is a direct result from 
Fig. 1  Pathology and infected cell types in PML, HSVE and CMVE. 
a LFB-PAS for myelin shows multiple demyelinated lesions in the 
white matter of a PML brain. Bar: 500 µm. b Double-staining for 
Pab 2003 (green) and SV40 (red) shows that most of the Pab 2003+ 
cells are also positive for SV40. The white arrowhead points at a sin-
gle Pab2003+/SV40− cell. Bar: 25 µm. c Staining for SV40 shows 
JC-infected oligodendrocytes at the border of a small demyelinated 
lesion. The inset shows an enlargement of an SV40+ oligodendrocyte. 
Bar: 200 µm. d Bizarre astrocyte stained for SV40 in the center of 
a large demyelinated lesion. The arrowheads point at macrophages. 
Bar: 20 µm. e Staining for GFAP (green) and SV40 (red) shows 
infected astrocytes in a PML lesion. Bar: 5 µm. f Confocal image of 
an area at the border of a demyelinating lesion in PML. The stain-
ing shows SV40+ (red)/CAII+ (blue) infected oligodendrocytes 
(white arrowheads) in between non-infected astrocytes stained for 
GFAP (green, white arrow). The yellow arrowheads point at two non-
infected oligodendrocytes. Bar: 10 µm. g HE stain in HSVE showing 
severe hemorrhage and moderate inflammation. Bar: 200 µm. h Stain-
ing for HSV-1 shows large numbers of infected cells in an HSVE 
lesion. Inset shows an HSV-1+ cell with a nuclear inclusion. Bar: 
50 µm. i Double-staining for GFAP (green) and HSV (red) shows an 
infected astrocyte in HSVE. Bar: 10 µm. j Here, staining for HSV 
shows an infected neuron. The TO-PRO-3 counterstain (blue) shows 
the nucleus of a satellite cell. Bar: 10 µm. k Double-staining for 
TPPP/p25 (green) and HSV (red) with TO-PRO-3 nuclear counter-
stain (blue) shows an infected oligodendrocyte in HSVE. Bar: 5 µm. 
l HE stain of a CMVE lesion showing inflammation and some hem-
orrhaging. Bar: 200 µm. m Staining for CMV reveals large numbers 
of infected cells in the cerebellum of a CMVE case. Inset shows an 
infected cell with typical owl’s eye morphology. Bar: 200 µm. n In 
CMVE many of the CMV+ (red) infected cells are GFAP+ astrocytes. 
o Double-staining for CMV (red) and TPPP/p25 (green) shows that 
in our material, lesions in CMVE do not contain infected oligoden-
drocytes
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the elimination of CD4+ T cells by HIV in these AIDS-
associated encephalitides. In all cases most of the infiltrat-
ing CD3+T cells also were CD8+ cells (Fig. 2d–f). In PML 
we found that 67% of the CD3 T cells were of the CD8 
phenotype. In HSVE 58% of the CD3 T cells were CD8+, 
while in CMVE this was 89% (Fig. 3a). Granzyme-B+ 
T lymphocytes were much less frequent. In PML, 18% of 
CD3+ T cells were GrB+, while in HSVE and CMVE these 
cells reached 19 and 31% respectively (Fig. 3a). Previously, 
in Rasmussen Encephalitis and paraneoplastic encephalitis 
we showed the presence of CD8+ GrB+ cytotoxic T cells 
targeting neurons [10, 11]. Here we investigated whether 
targeting of virus-infected cells could be found. First, we 
quantified and calculated the ratio between virus-infected 
cells and CD8+ as well as the ratio between virus-infected 
cells and GrB+ cells. These ratios were about four times 
lower in CMVE than in PML, but, probably due to large 
interindividual variety, these differences were not significant 
(Fig. 3b, c). To reveal objective differences in the targeting 
of infected cells we quantified the appositions of single or 
multiple (2 or more) CD8+ (Fig. 3b) or GrB+ cells (Fig. 3c) 
to virus-infected cells. Surprisingly, we found that in PML 
both single (Fig. 2g) as well as multiple appositions of 
CD8+ (Figs. 2g, 3b) or GrB+ cells (Figs. 2j, 3c) were sig-
nificantly less frequent than in CMVE. In addition, we also 
found that CMVE (Fig. 2i) contains more multiple CD8+ T 
cell appositions than HSVE (Figs. 2h, 3b). The frequency 
of single and multiple GrB+ appositions in HSVE were 
in between those of PML and CMVE (Fig. 3c). A specific 
step in active killing of target cells by cytotoxic T cells is 
polarization of the cytoplasm and upregulation and redirec-
tion of GrB granules towards the target cell as described 
in in vitro cytotoxicity [47]. In addition to the above-men-
tioned quantitative findings, we did observe polarization of 
GrB towards the virus-infected cell in HSVE (Fig. 2k) and 
CMVE (Fig. 2l) but not in PML (Fig. 2j).
Fig. 2  Immune mechanisms in PML, HSVE and CMV. a–f show 
identical areas of consecutive sections stained with CD3 (a–c) and 
CD8 (d–f) in PML, HSVE and CMVE. The stainings show that in 
all these encephalitides most infiltrating CD3+ T cells are cytotoxic 
CD8+ T cells. Bars: 100 µm Double-stainings with virus markers 
(blue) and CD8 (brown). g Few CD8+ T cells (arrowheads) can be 
seen between SV40+ cells. The inset shows one of the few apposi-
tions of CD8+ T cells to an infected oligodendrocyte. Bar: 10 µm. 
h In HSVE, CD8+ T cells are intermingled with small HSV+ cells. 
The arrowhead points at a single apposition. The inset shows 2 
CD8+ T cells in apposition to an infected neuron. Bar: 10 µm i In 
CMVE many large infected cells and relatively few CD8+ T cells can 
be seen. Despite the low numbers of CD8+ T cells, multiple apposi-
tions (arrowheads) are present. The inset shows a cluster of CMV+ 
cells with CD8+ T cell appositions. Bar: 10 µm. Double-stainings 
with virus markers (red) and GrB (brown). j In PML multiple GrB+ 
lymphocytes (arrowheads) can be seen in between JC-infected cells. 
However, appositions of GrB+ cells to infected cells are absent. Bar: 
20 µm. k In HSVE, a GrB+ T cell with polarized GrB is found in 
apposition to a HSV+ cell (arrowhead). Bar: 20 µm. l In CMVE, sin-
gle (s) and multiple (m) appositions of GrB+ lymphocytes to CMV-
infected cells can be seen. Bar: 20 µm
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Cell death mechanisms in virus‑infected cells
PML
Activated caspase-3 and caspase-6 play a central role in 
caspase-mediated apoptosis which can be induced by CD8+ 
cytotoxic T cells through release of GrB. We hypothesized 
that if cytotoxic GrB+ T cells eliminate virus-infected cells 
in the various encephalitides, we should be able to detect 
apoptotic virus-infected cells with upregulated activated 
caspase-3, or loss of caspase-6 from mitochondria [23]. 
Previously, we have shown that upregulation of activated 
caspase-3 is found in the cytoplasm in apoptotic cells, [3–
5, 13]. Here, in normal control brain, activated caspase-3 
upregulation was not present. In PML, staining for acti-
vated caspase-3 showed the presence of small apoptotic 
cells (Fig. 4a) that co-localized with CD3 (inset, Fig. 4a) 
and therefore were characterized as lymphocytes. Analysis 
of infected oligodendrocytes at the border of demyelinat-
ing lesions showed that none of these cells were reactive 
Fig. 3  Quantitative analysis of immune cells and interactions with 
virus-infected cells. a Quantitative analysis of the numbers of CD3+, 
CD8+ GrB+, CD4+, CD20+ and CD138+ cells in PML, HSVE and 
CMVE. Average numbers of CD3+ T lymphocyte numbers are lower 
in CMV than in PML and HSVE. In addition the number of CD4+ 
T helper cells in HSVE is higher than in PML and CMVE. b Analy-
sis of the ratio of virus-infected neural cells and CD8+ cells and the 
percentage of single and multiple appositions of CD8+ cells to virus-
infected cells in PML, CMVE and HSVE. PML has significant less 
single appositions of CD8+ cells to virus-infected cells than HSVE 
and CMVE. CMVE has significant more multiple appositions of 
CD8+ cells to virus-infected cells than PML and HSVE. c Analy-
sis of the ratio of virus-infected neural cells and GrB+ T cells and 
the percentage of single and multiple appositions of GrB+ T cells to 
virus-infected cells in PML, CMVE and HSVE. PML and CMVE dif-
fer in the number of both single and multiple appositions of GrB+ T 
cells to virus-infected cells. All numbers in (a–c) are given as aver-
age ± Standard Error of Means (SEM). *Indicates significant differ-
ence (p < 0.05), **indicates significant difference (p < 0.01)
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for caspase-3 (Fig. 4a; Table 2). In control brain (Fig. 4b) 
and in uninfected cells (Fig. 5g–h), caspase-6 was present 
in mitochondria. In PML, caspase-6 immunoreactivity was 
strongly increased. In infected oligodendrocytes, caspase-6 
was seen in a granular mitochondrial pattern (Fig. 4c), 
with no detectable translocation to the cytoplasm being 
observed.
Since oligodendrocyte death in our PML cases does 
not seem to result from cytotoxic T cell induced activa-
tion of the caspase-cascade, we investigated caspase-
independent pathways of cell death. One of these path-
ways is the Poly(ADP-ribose) polymerase-1-(PARP-1) 
dependent cell death pathway in which poly-(ADP-ribose) 
(PAR) and apoptosis-inducing factor (AIF) are some of 
the key molecules [23]. In normal cells of control brain, 
weak staining for PAR was seen in the nucleus of cells 
(Fig. 4d). In PML, enhanced PAR reactivity in uninfected 
cells was observed (Fig. 4e). In addition, in some of the 
infected oligodendrocytes, PAR not only was present in 
the nucleus, but also was seen to translocate to the cyto-
sol (Fig. 4e–h). Some of these cells showed largely degen-
erating cytoplasms with large vacuoles (Fig. 4g). Staining 
for AIF in control brain revealed the granular presence of 
AIF restricted to the mitochondria of normal cells (Fig. 4i). 
In PML brain, AIF reactivity was upregulated in the mito-
chondria of uninfected cells (Fig. 4j–l) as well as in mito-
chondria of most of the infected oligodendrocytes (Fig. 4n). 
In part of the infected cells, however, we observed that 
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staining of AIF was largely absent from the mitochondria 
and was translocated to the nucleus (Fig. 4m, o, p). Quan-
tification showed that AIF translocation to the nucleus was 
detectable in 1.6% of these cells (Table 2). Confocal fluo-
rescence triple staining for SV40, PAR and AIF confirmed 
the presence of infected cells with simultaneous transloca-
tion of PAR from nucleus to cytoplasm and AIF from mito-
chondria to nucleus (Fig. 4p).
In normal adult brain, oligodendrocyte cell bodies do 
not express myelin proteins such as major oligodendro-
cyte glycoprotein (MOG) and proteolipid protein (PLP). 
During analysis of our PML tissues we however noticed 
that some of the infected oligodendrocytes at the border 
of demyelinated lesions strongly express MOG (Fig. 4q) 
and PLP (Fig. 4r) in the cell bodies. These findings suggest 
that these proteins are trapped in the endoplasmic reticu-
lum (ER), something we also have shown previously in 
PLP overexpressing transgenic animals with ER stress [13]. 
Analysis of protein disulfide isomerase (PDI) and Binding 
Protein/Glucose Regulated Protein 78 (BiP/GRP78), both 
involved in endoplasmic reticulum stress, revealed strong 
upregulation in such infected oligodendrocytes (Fig. 4s, 
t). ER stress also has been shown to induce hypoxia induc-
ing factor-1α (HIF-1α) [8]. Previously, we already showed 
the presence of HIF-1α in cases of PML [1]. Here, dou-
ble-staining for HIF-1α with SV40 shows that HIF-1α is 
strongly upregulated in some of the infected cells (Fig. 4u).
HSV encephalitis
To detect apoptosis in infected cells we performed double-
labeling for caspase-3 and HSV. These stainings revealed 
the presence of large numbers of positive cells of which, 
based on their morphology, most were recognized as astro-
cytes (Fig. 5a). Quantification of these stainings showed 
that on average 0.4% of infected cells were caspase-3+ 
(Table 2). The presence of infected apoptotic astrocytes 
was confirmed by triple labeling of HSV with caspase-3 
and GFAP (Fig. 5b). Many of these apoptotic astrocytes 
showed degeneration of the astrocytic processes (Fig. 5b–
c) as also seen previously in Rasmussen encephalitis 
[5]. Besides these astrocytes also some infected neurons 
showed caspase-3 reactivity (Fig. 5d). In many of these 
apoptotic cells, HSV immunostaining became less strong 
and HSV antigens were only present in the cell body of 
these cells (Fig. 5e–f). HSVE brains also were stained for 
caspase-6. In both uninfected (Fig. 5g–h) as well as in 
many HSV-infected cells (Fig. 5i–j), caspase-6 was present 
in mitochondria. In areas with large numbers of degenerat-
ing caspase-3+ cells we also found caspase-6+ cells with 
apoptotic nuclei (Fig. 5k). Interestingly, such apoptotic 
cells showed a diffuse cytoplasmic staining for caspase-6 
and loss of mitochondrial caspase-6 (Fig. 5k). Like in 
caspase-3 stainings, many of these caspase-6+ cells were 
astrocytes (Fig. 5l), although also cells with oligodendro-
cyte morphology with cytoplasmic staining of caspase-6 
(Fig. 5m) were found.
Since it was difficult to discriminate small HSV-infected 
cells from normal cells, we also analyzed HSVE brains 
by performing quadruple labeling of HSV with PAR, AIF 
and nuclear DAPI stain. These stainings clearly showed 
Fig. 4  Cell death mechanisms of infected cells in PML. a Stain-
ing for caspase-3 shows a single apoptotic lymphocyte (arrow). An 
infected oligodendrocyte (arrowhead) is caspase-3 negative. Bar: 
20 µm. The inset shows a double-staining for caspase-3 (blue) and 
CD3 (red) showing that the cell indicated by the arrow is an apop-
totic T lymphocyte. b Staining for caspase-6 in a control brain shows 
a punctate mitochondrial staining in white matter oligodendrocytes. 
Bar: 20 µm. c Caspase-6 staining in PML shows upregulation of cas-
pase-6 in infected cells (arrowheads) but no loss of caspase-6 from 
the mitochondria. Bar: 20 µm. d Staining for PAR in control brain. 
Oligodendrocytes show weak PAR reactivity in the nucleus. Bar: 
20 µm. e PAR in PML brain. Upregulation of PAR is seen in most 
cells. An infected oligodendrocyte (arrowhead), however, reveals 
translocation of PAR reactivity from the nucleus to the cytoplasm. 
Bar: 20 µm. f Another example of an infected cell with translocation 
of PAR to the cytoplasm. Bar: 10 µm. g Cell with PAR immunore-
activity and vacuolation in the cytoplasm suggesting an advanced 
stage of degeneration. Bar: 10 µm. h Triple staining for PAR (green) 
SV40 (red) and CAII (blue) revealing translocation of PAR from the 
nucleus to the cytoplasm of an infected oligodendrocyte. The arrow-
head points at an uninfected CAII+ oligodendrocyte. Bar: 10 µm. i 
Staining for AIF in a control brain. White matter oligodendrocytes 
show a granular immunoreactivity of AIF in mitochondria. Bar: 
20 µm. Cellular localization of AIF in PML. Double-staining for 
AIF (green) and a mitochondrial marker (Red). j Here AIF is seen in 
mitochondria of typical uninfected oligodendrocytes. Bar: 10 µm. k 
Again, an uninfected cell (probable astrocyte) shows co-localization 
of AIF and anti-Mitochondria in mitochondria. l Also this round mac-
rophage shows strong double-labeling indicating mitochondrial local-
ization of AIF. m AIF reactivity in PML brain. Mitochondrial AIF is 
upregulated in many cells. Two infected cells (arrowheads) however 
show little AIF in mitochondria but strong immunoreactivity in the 
nucleus, suggesting translocation of AIF. Bar: 20 µm. n Triple stain-
ing for AIF (green) anti-Mitochondria (red) and SV40 (blue) shows 
that in this infected cell AIF is present in mitochondria. Bar: 10 µm. 
o The same triple staining shows another SV40 (blue) infected cell. 
Here, AIF (green) however is seen to translocate from mitochondria 
(red) to a nuclear position. The inset shows AIF and anti-Mitochon-
dria in the absence of the blue (SV40) channel. Bar: 10 µm. p Triple 
staining for JC Virus (blue), PAR (green) and AIF (red). The infected 
cell indicated by the white arrowhead shows translocation of PAR 
from the nucleus to the cytoplasm. At the same time diffuse translo-
cation of AIF to the nucleus is seen (the inset only shows the green 
PAR channel and the red AIF channel). The uninfected cell on the 
right indicated by the yellow arrowhead shows neither translocation 
of PAR nor from AIF. Bar: 20 µm. q staining for MOG shows cell 
bodies of infected cells. Bar: 15 µm. r An infected cell on the border 
of a demyelinated lesion also shows reactivity for PLP. Bar: 10 µm. 
s Double-staining for SV40 (green) and PDI (red) shows an infected 
cell with strong expression of PDI. Bar: 20 µm. t Such infected cells 
(green) in addition show strong reactivity for BiP/GRP78 (red). Bar: 
10 µm. u Staining for HIF-1α (blue) shows strong nuclear upregula-
tion in a single infected cell (SV40+, red) while other infected cells 
only show some weak cytoplasmic staining for HIF-1α. Bar: 20 µm
◂
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Fig. 5  Cell death mechanisms of infected cells in HSVE. a Double-
staining for caspase-3 (blue) and HSV (red). At this magnification, 
HSV is only seen in the cell body of non-apoptotic cells. The inset 
shows a single staining for caspase-3 and shows the nuclear conden-
sation and fragmentation of this cell. Bar: 100 µm. b Triple staining 
for caspase-3 (green), GFAP (red) and HSV (blue) showing that the 
cell indicated by the arrow is an apoptotic astrocyte. The GFAP in the 
distal degenerating processes is lost. The inset shows this cell with 
separate green, red and blue layers. Bar: 10 µm. c A higher magni-
fication of a double-staining for HSV (red) and caspase-3 (blue). 
Here the arrowhead points at an apoptotic cell which shows some 
HSV antigenicity in the cell body. On the left an HSV positive cell 
is seen. Bar: 20 µm. d Double-staining for HSV and caspase-3. Here 
the arrowhead points at a double-stained cell, which is a neuron as 
suggested by its morphology. Bar: 20 µm. The stainings in (e, bar 
7.5 µm) and (f, bar: 10 µm) show caspase-3+ (green) apoptotic cells 
which show HSV (red) immunoreactivity in the cell body. Cellular 
localization of Caspase-6. g Staining for caspase-6 (red) and anti-
Mitochondria (green) shows that in uninfected astrocytes caspase-6 
is localized in mitochondria. Bar: 10 µm. h Also in this normal neu-
ron AIF (red) is in a mitochondrial position. Bar: 7.5 µm. i Fluores-
cence labeling for caspase-6 (green) and HSV (red). In this infected 
cell most of the caspase-6 is seen in a granular mitochondrial pattern 
suggesting that this cell is not apoptotic. Bar: 7.5 µm. j This infected 
(probably oligodendrocyte) cell shows strong HSV reactivity (red) 
while caspase-6 (green) is present in few mitochondria. Bar: 10 µm. 
k Single staining for caspase-6. The arrowhead points at a cell with 
diffuse labeling of the cytoplasm and a fragmented nucleus. Bar: 
20 µm. l Caspase-6 reactivity in an apoptotic astrocyte of which the 
processes show fragmentation. Bar: 20 µm. m Here double-labeling 
shows a diffuse staining for caspase-6 (green) and reduced HSV reac-
tivity (red, only in nuclear local ization) suggesting that this cell is 
undergoing apoptosis. Quadruple stainings for PAR (green), HSV 
(red), AIF (white) and DAPI nuclear counterstain (blue). n The white 
arrowhead points at a non-apoptotic HSV-infected cell. PAR is pre-
sent in the nucleus while AIF is located in a granular mitochondrial 
location. Bar: 7.5 µm. The yellow arrowhead points at a non-infected 
cell. Again PAR is found in the nucleus while AIF is located in mito-
chondria. o In this HSV+ cell (red) the nucleus (blue) clearly shows 
fragmentation. PAR (green) however is still present in a nuclear posi-
tion while AIF (white) remains in the mitochondria. Bar: 7.5 µm. p 
Another infected cell with nuclear fragmentation indicating apopto-
sis. PAR again is present in the nucleus while AIF is present in mito-
chondria. In this case HSV reactivity (red) is reduced and only pre-
sent in a nuclear position as also seen in Fig. 5e, f, m. Bar: 7.5 µm
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that in infected cells, PAR always remained in the nucleus 
(Fig. 5n–p). Staining for AIF in HSV-infected cells, on the 
other hand, never was seen outside of the mitochondria 
(Table 2; Fig. 5n–p). Furthermore, part of the HSV+ cells, 
again showed a diminished reactivity for HSV, present only 
in nucleus and cell body (Fig. 5p).
CMV encephalitis
In CMVE, like in PML, activated caspase-3 again could 
be found in lymphocytes. In addition we found strong 
Table 2  Percentage of infected cells with caspase-3 or nuclear AIF 
expression
Data are given as percentage ± SEM
* p values: PML vs. HSV, p = 0.0013, PML vs. CMV, p = 0.02, 
CMV vs. HSV, p = 0.20
** p values: PML vs. HSV, p = 0.006, PML vs. CMV, p = 0.004, 
CMV vs. HSV, p > 0.99
PML HSV CMV
Caspase-3 0.0 ± 0.0* 0.40 ± 0.13 4.97 ± 1.77
Nuclear AIF 1.6 ± 0.40** 0.00 ± 0.00 0.00 ± 0.00
Fig. 6  Cell death mechanisms of infected cells in CMVE. a Infected 
cell (arrowhead) strongly stained for activated caspase-3. The CMV-
infected cells on the left upper corner (arrows) show no reactivity for 
caspase-3. Bar: 20 µm. b, c Two examples of infected cells double-
stained for CMV (green) and upregulation of activated caspase-3 
(red). Bar in b: 20 µm. Bar in c: 10 µm. d, e Staining for caspase-6. 
In d the arrow points at a CMV-infected cell with very little cas-
pase-6+ mitochondria. The arrowhead, on the other hand, points at 
an infected cell with a strong cytoplasmic localization of caspase-6, 
suggesting apoptosis. Bar: 20 µm. e Here, the arrowhead points at 
an infected cell with a mitochondrial staining for caspase-6. Notice 
that the mitochondria in this cell are gathered close to the cell mem-
brane. The other two infected cells (arrows) show both caspase-6 in a 
granular (mitochondrial) as well as cytoplasmic location. Bar: 20 µm. 
f Confocal fluorescence staining shows a typical CMV-infected cell 
with caspase-6 immunoreactivity (red) outside of mitochondria 
(green). Bar: 7.5 µm. g Staining for PAR shows immunoreactivity in 
the nucleus of an infected cell (arrowhead). In none of the infected 
cells did we observe PAR in a cytoplasmic location. Bar: 20 µm. h 
This staining reveals a mitochondrial localization of AIF in a large 
infected cell. Again, mitochondria are located closely to the cell 
membrane. Staining for AIF never showed any staining in the nuclei 
of infected cells, suggesting the absence of AIF-associated apoptotic 
pathways in these cells. Bar: 20 µm. i Fluorescence double-staining 
for PAR (green) and AIF (red). The white arrowhead points at an 
infected cell. Weak PAR reactivity is present in a nuclear position 
while AIF is present in a granular mitochondrial localization. Bar: 
20 µm
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cytoplasmic upregulation of caspase-3 in infected cells 
(Fig. 6a). This finding was confirmed in double-labeling 
studies for caspase-3 and CMV where almost 5% of CMV+ 
cells were reactive for caspase-3 (Table 2; Fig. 6b, c). In 
comparison to other cells, part of the CMV-infected cells 
only revealed little granular caspase-6 immunoreactivity 
(arrow Fig. 6d). Some of the infected cells with apoptotic 
nuclei showed strong cytoplasmic staining (arrowhead 
Fig. 6d) in line with caspase-mediated apoptosis. Other 
infected cells however revealed intense caspase-6 immu-
noreactivity in a granular mitochondrial pattern (Fig. 6e). 
Notably, unlike in uninfected cells, caspase-6+ mitochon-
dria in some infected cells seemed to be located close to 
the cell membrane (Fig. 6e). In other CMV-infected cells, 
caspase-6 immunoreactivity was seen both in mitochon-
dria as well as diffusely dispersed in the cytoplasm (arrows 
Fig. 6e, f). To confirm that the cell death mechanism in 
CMVE differs from PML, we also investigated PAR and 
AIF expression. Immunoreactivity for PAR in infected cells 
was solely present in the nucleus and never found in a cyto-
plasmic localization (Fig. 6g, i). In addition, much like the 
staining for caspase-6, mitochondrial AIF showed a granu-
lar pattern mainly located at the outer side of the cytoplasm 
close to the cell membrane (Fig. 6h, i). AIF reactivity in 
CMV-infected cells was never found to translocate to the 
nucleus (Table 2). Altogether, the absence of translocation 
of PAR and AIF, the presence of activated caspase-3 and 
the translocation of caspase-6 from mitochondria to cyto-
plasm in CMV and HSV-infected cells strongly suggest 
that these cells, unlike cells in PML, die by caspase-medi-
ated apoptosis.
Discussion
The introduction of new highly potent anti-inflammatory 
drugs, such as Natalizumab and Rituximab has led to an 
increasing incidence of PML in cancer and autoimmune 
disease patients [6]. In addition, variants of PML with co-
existence of the immune reconstitution inflammatory syn-
drome (IRIS), also known as PML-IRIS, have in recent 
years been brought up [6, 35]. Previously, we and others 
have shown that in PML-IRIS the numbers of inflamma-
tory T cells and plasma cells are increased about 50-fold 
as compared to PML [34, 36]. Analysis of PML and PML-
IRIS cases showed that numbers of infected cells in PML-
IRIS were decreased and direct apposition of cytotoxic T 
cells towards virus-infected cells was increased, suggesting 
that the reconstituted immune system in PML-IRIS indeed 
eliminates virus-infected cells more rigorous than in PML 
[33]. In that study we also analyzed apoptosis of infected 
cells in PML or PML-IRIS but did not detect any activated 
caspase-3 immunoreactive oligodendrocytes [33].
Since the question regarding the death of infected cells 
in PML remained open, we decided to analyze cell death 
pathways and inflammatory reactions in more detail. Like 
in our previous study [33], in PML we could not demon-
strate a significant attack of JC-infected cells by cytotoxic 
T cells. This is in contrast with CMVE and HSVE where 
cytotoxic GrB+ T cells in apposition to virus-infected cells 
were more obvious. Notably, the absence of cytotoxic T 
cells targeting infected oligodendrocytes in PML is not 
because of a lack of MHC class I expression, since we have 
shown previously that these cells reveal strong MHC class 
I immunoreactivity [6]. Probably one of the reasons for a 
more effective elimination of virus-infected cells in CMVE 
compared to PML is that within lesions the ratio of GrB+ 
T cells per virus-infected cell seems higher in CMVE. In 
HSVE absolute numbers of CD3+ T cells and CD4+ T 
helper cells were much higher than in CMVE and PML. 
This may be related to the AIDS-associated compromised 
immune system. The relatively low number of appositions 
in HSVE probably again is a reflection of the unfavorable 
ratio between HSV-infected cells and GrB+ T cells. Over-
all, our results suggest that in PML the immune system is 
not able to contain the virus infection due to a low num-
ber of inflammatory cells relative to the number of infected 
oligodendrocytes.
Previously, in animal models for EAE we showed that 
oligodendrocytes and astrocytes undergo caspase-3-me-
diated apoptosis after attack by CD8+ cytotoxic T cells 
[16, 42]. In addition, in human Rasmussen Encephalitis 
we revealed that cells are attacked by cytotoxic T cells 
and undergo caspase-3 mediated apoptosis [5, 10]. These 
findings suggest that elimination of neural cells by cyto-
toxic T cells predominantly is achieved by induction of 
caspase-mediated apoptosis. Here, in CMVE and HSVE 
we indeed detected infected cells with caspase-3 reactivity 
in areas where infected cells were attacked by cytotoxic T 
cells. These findings are in line with findings by DeBiasi 
et al. who detected caspase-3 in infected cells in acute HSV 
encephalitis and congenital CMV encephalitis of mostly 
young children [19]. These authors at that time however 
could not demonstrate a role of the immune system as we 
did here. Our findings in CMVE and HSVE are in sharp 
contrast with PML, where we did not find any caspase-3 
reactivity in the cytoplasm of JC-infected cells.
Despite being a central pathological feature, until now 
very few studies dealt with the question of oligodendrocyte 
death in PML. One paper favored apoptosis as the death 
inducing mechanism [41], whereas the other study argued 
that apoptosis is not involved in oligodendrocyte death 
since these cells are protected by the anti-apoptotic protein 
survivin [40]. Richardson-Burns et al. showed DNA frag-
mentation in oligodendrocytes by TUNEL. They however 
did not identify morphological changes in the nucleus, as 
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usually seen in apoptotic cells. Moreover, caspase-3 in this 
study was observed in the nucleus rather than the cyto-
plasm. Although these findings are striking at first glance, 
there are some caveats which at that time were not con-
sidered. First, it has been reported that DNA viruses cause 
DNA double-strand breaks in host cells [25, 28, 44, 49] 
and thus it is conceivable that rather than apoptosis or 
necrosis, the TUNEL staining detects DNA double-strand 
breaks induced by the JC virus. Secondly, we and others 
have shown that apoptotic cells with nuclear condensa-
tion or the presence of apoptotic bodies show cytoplasmic 
rather than nuclear distribution of activated caspase-3 [3, 
13, 14, 20, 45]. Moreover, nuclear caspase-3 has been sug-
gested to play a role other than in apoptosis [38].
Instead of activated caspase-3, infected degenerating oli-
godendrocytes in PML expressed nuclear AIF and cytoplas-
mic PAR. In addition, in these cells we could show signs of 
ER stress and upregulation of hypoxia inducible factor-1α 
(HIF-1α). The translocation of PAR and AIF suggests 
that these cells died by a pathway designated as parthan-
atos [18, 23]. Interestingly, parthanatos is often linked to 
cell death induced by hypoxia [32]. Also in PML a role of 
hypoxic mechanisms has been suggested [30, 39]. Hypoxia 
might be induced by molecules such as nitric oxide or oxy-
gen radicals produced by macrophages and microglia. In 
addition, hypoxic pathways may result from thrombotic 
occlusion of small inflamed vessels [21]. Another possi-
bility, however, is that a virtual hypoxia is induced in JC-
virus-infected cells indirectly. By taking over the host’s 
protein production machinery, viruses can induce endo-
plasmic reticulum (ER) stress [22]. More specifically, ER 
stress can be induced by so-called viroporins [22]. In JC-
virus-infected cells, agnoprotein acts as such a viroporin 
[46]. ER stress by viroporins is induced by multiple mecha-
nisms such as membrane remodeling, delayed glycopro-
tein trafficking and disruption of calcium homeostasis. The 
latter results in an increase in cytosolic calcium followed 
by calcium-dependent cell death signaling and finally cell 
death [22, 46]. ER stress therefore, can act as an intracel-
lular inducer of hypoxic pathways as shown in intermittent 
hypoxia where ER stress induced HIF-1α activity [8].
In summary, our results show that, compared to CMVE 
and HSVE, interaction of GrB+ cytotoxic T cells with 
infected oligodendrocytes are much less frequent in PML 
lesions. Furthermore, in CMVE and HSVE, infected cells 
seem to die by caspase-mediated apoptotic pathways. In 
PML however, infected oligodendrocytes show transloca-
tion of PAR and AIF, hypoxia and ER stress which are all 
compatible with the parthanatos pathway of cell death. Our 
findings suggest that, unlike in HSVE and CMVE, in PML 
the immune system not adequately enough eradicates JC-
infected oligodendrocytes. Instead these cells seem to die 
by virus-induced changes in homeostatic pathways.
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